APP and Alzheimer disease: The measurement of in vivo lysosomal pH in transgenic mouse models for AD indicated that the emergence of lysosomal acidification deficits precedes Aβ depositions and that as disease progresses, neurons build up Aβ/APP-CTF selectively in perinuclear de-acidified lysosomes, leading to lysosomal damage43.